Duke GI’s Esophageal Program provides state-of-the-art care for patients with swallowing dysfunction and esophageal disorders, including complex gastroesophageal reflux disease (GERD) and its complications such as Barrett’s esophagus BE), esophageal motility disorders such as achalasia, and eosinophilic esophagitis (EoE). We offer the most advanced esophageal diagnostics and therapeutics available, including functional luminal impedance planimetry (EndoFLIP), esophageal high resolution manometry, wireless pH testing as well as transoral incisionless fundoplication (TIF), peroral endoscopic myotomy (POEM), and a spectrum of therapeutic modalities for endoscopic treatment of BE.
The care of esophageal disorders often requires a multidisciplinary approach, and we are proud that Duke GI’s esophageal experts partner with colleagues in Thoracic and Minimally Invasive Surgery through The Esophageal Center at Duke (the ECD). The ECD centralizes and coordinates comprehensive testing, diagnosis, and treatment plans for patients in a single convenient clinic location.
Duke GI’s esophageal specialists provide high quality clinical care and are leaders in advancing our understanding of swallowing disorders through involvement in clinical trials for novel treatments for conditions that include GERD and EoE. Our team has helped draft evidence-based national practice recommendations that guide care and are actively involved in health services research to improve its implementation.
Providers: David Leiman, MD, MSHP, (Program Director), Darin Dufault, MD, Sahar Ghassemi, MD, Alexander Reddy, MD, Richard Wood, Jr., MD, Lauren Barkley, AGNP-C, Rebecca Ryder, PA-C, Rachelle Thomasson, MSN, AGNP-C, RN